Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending September 30, 2022 was 17.5 (a 37.91% increase compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA increased by 56.35%
- Annual Net Debt/EBITDA for 2022 was 3.33 (a -2.74% decrease from previous year)
- Annual Net Debt/EBITDA for 2021 was 3.42 (a -31.41% decrease from previous year)
- Annual Net Debt/EBITDA for 2020 was 4.99 (a 6.65% increase from previous year)
Visit stockrow.com/BDX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Becton, Dickinson and Company
Most recent Net Debt/EBITDAof BDX including historical data for past 10 years.Interactive Chart of Net Debt/EBITDA of Becton, Dickinson and Company
Becton, Dickinson and Company Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 17.5 | 12.69 | 12.64 | 3.33 |
| 2021 | 11.19 | 23.02 | 14.05 | 13.92 | 3.42 |
| 2020 | 7.99 | 76.65 | 17.74 | 20.78 | 4.99 |
| 2019 | 18.32 | 26.26 | 14.51 | 24.0 | 4.68 |
| 2018 | 11.57 | 15.45 | 17.45 | 28.59 | 5.81 |
| 2017 | 39.49 | 5.75 | 84.71 | 11.57 | 1.79 |
| 2016 | 7.24 | 23.36 | 10.81 | 11.87 | 3.79 |
| 2015 | 14.4 | 16.15 | 22.13 | 23.2 | 5.01 |
| 2014 | 2.37 | 1.85 | 1.92 | 2.23 | 0.47 |
| 2013 | 2.41 | 5.27 | 2.69 | 2.59 | 0.64 |
| 2012 | 2.4 | 3.06 | 2.75 | 3.62 | 0.76 |
Business Profile of Becton, Dickinson and Company
Sector: Healthcare
Industry: Medical Instruments & Supplies